X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12484) 12484
Magazine Article (13) 13
Book / eBook (11) 11
Conference Proceeding (10) 10
Publication (4) 4
Web Resource (4) 4
Book Chapter (2) 2
Dissertation (2) 2
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9168) 9168
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (6331) 6331
male (5311) 5311
animals (4917) 4917
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (4616) 4616
statins (4438) 4438
pharmacology & pharmacy (4041) 4041
female (3746) 3746
middle aged (2698) 2698
simvastatin (2455) 2455
cholesterol (2212) 2212
aged (2180) 2180
atorvastatin (1965) 1965
rats (1911) 1911
adult (1648) 1648
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1433) 1433
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1424) 1424
simvastatin - pharmacology (1395) 1395
pravastatin (1385) 1385
cardiac & cardiovascular systems (1365) 1365
risk factors (1301) 1301
mice (1297) 1297
hydroxymethylglutaryl-coa reductase inhibitors (1234) 1234
atorvastatin calcium (1219) 1219
atherosclerosis (1216) 1216
cells, cultured (1070) 1070
risk (1059) 1059
heptanoic acids - pharmacology (1039) 1039
peripheral vascular disease (1034) 1034
pyrroles - pharmacology (1020) 1020
lipids (1017) 1017
treatment outcome (1012) 1012
dose-response relationship, drug (998) 998
statin (992) 992
hypercholesterolemia - drug therapy (970) 970
lovastatin - pharmacology (970) 970
therapy (942) 942
cholesterol, ldl - blood (931) 931
biochemistry & molecular biology (930) 930
analysis (925) 925
prevention (908) 908
expression (874) 874
lovastatin (873) 873
hypercholesterolemia (865) 865
cholesterol - blood (863) 863
hmg-coa reductase (857) 857
hydroxymethylglutaryl coa reductases - metabolism (844) 844
coronary-heart-disease (819) 819
inflammation (815) 815
coa reductase inhibitors (772) 772
anticholesteremic agents - pharmacology (762) 762
research (737) 737
time factors (732) 732
antilipemic agents (730) 730
drug interactions (717) 717
disease (690) 690
rosuvastatin (678) 678
drug therapy (677) 677
medicine & public health (663) 663
cardiovascular diseases - prevention & control (659) 659
nitric-oxide synthase (656) 656
pravastatin - pharmacology (631) 631
hydroxymethylglutaryl-coa reductase inhibitors - pharmacokinetics (628) 628
cardiovascular disease (627) 627
rats, sprague-dawley (615) 615
rosuvastatin calcium (613) 613
anticholesteremic agents - therapeutic use (610) 610
disease models, animal (609) 609
drug therapy, combination (608) 608
cardiovascular diseases (601) 601
cholesterol - metabolism (596) 596
coenzyme-a reductase (586) 586
in-vitro (586) 586
oxidative stress (582) 582
mortality (581) 581
c-reactive protein (579) 579
aged, 80 and over (575) 575
lipids - blood (572) 572
apoptosis (567) 567
health aspects (562) 562
endothelium, vascular - drug effects (538) 538
metabolism (538) 538
simvastatin - therapeutic use (538) 538
care and treatment (536) 536
cardiovascular-disease (535) 535
cell line (531) 531
pharmacology (521) 521
myocardial-infarction (515) 515
internal medicine (496) 496
heptanoic acids - therapeutic use (493) 493
retrospective studies (491) 491
pyrroles - therapeutic use (490) 490
enzymes (486) 486
rats, wistar (481) 481
hyperlipidemias - drug therapy (479) 479
liver - metabolism (473) 473
medicine, research & experimental (473) 473
cardiology (467) 467
cardiovascular (467) 467
fluvastatin (467) 467
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12283) 12283
Japanese (216) 216
French (61) 61
Spanish (51) 51
German (36) 36
Russian (35) 35
Chinese (33) 33
Polish (22) 22
Hungarian (17) 17
Italian (16) 16
Portuguese (16) 16
Dutch (9) 9
Finnish (5) 5
Czech (3) 3
Hebrew (3) 3
Norwegian (3) 3
Romanian (2) 2
Turkish (2) 2
Bosnian (1) 1
Danish (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Lee, S.J and Lee, I and Lee, J and Park, C and Kang, W.K
British journal of cancer, ISSN 0007-0920, 07/2014, Volume 111, Issue 3, pp. 497 - 505
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 08/2001, Volume 108, Issue 3, pp. 399 - 405
.... We show here, using a chemotaxis assay of bone marrow mononuclear cells in vitro and EPC culture assay of peripheral blood from simvastatin-treated animals in vivo, that the HMG-CoA reductase... 
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | IN-VITRO | GENE | ANGIOGENESIS | VASCULOGENESIS | PROTEIN-KINASE | PHOSPHATIDYLINOSITOL 3-KINASE | AKT | ANGIOPOIETIN-1 | NEOVASCULARIZATION
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 08/2007, Volume 50, Issue 2, pp. 377 - 383
Journal Article
Journal Article
Nature medicine, ISSN 1546-170X, 2008, Volume 14, Issue 7, pp. 767 - 772
Journal Article
Journal Article
Circulation research, ISSN 1524-4571, 2017, Volume 120, Issue 1, pp. 229 - 243
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their primary mechanism of action is the lowering of serum cholesterol... 
hydroxymethylglutaryl-CoA reductase inhibitors | rho-associated kinases | cardiovascular diseases | cholesterol, LDL | vascular diseases | CARDIAC & CARDIOVASCULAR SYSTEMS | CoA reductase inhibitors | ACTIVATED RECEPTOR-GAMMA | HIGH-DOSE ATORVASTATIN | NITRIC-OXIDE SYNTHASE | RHO-KINASE-ACTIVITY | HMG-COA REDUCTASE | hydroxymethylglutaryl | ACUTE CORONARY SYNDROMES | RANDOMIZED CONTROLLED-TRIAL | VASCULAR SMOOTH-MUSCLE | HUMAN ENDOTHELIAL-CELLS | LDL | cholesterol | PERIPHERAL VASCULAR DISEASE | PLACEBO-CONTROLLED TRIAL | HEMATOLOGY | Cardiovascular Diseases - physiopathology | Cardiovascular Diseases - drug therapy | Humans | Cholesterol, LDL - antagonists & inhibitors | Cardiovascular System - drug effects | Cardiovascular Diseases - genetics | Cholesterol, LDL - genetics | Cardiovascular System - physiopathology | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Clinical Trials as Topic - methods | Genetic Pleiotropy - genetics | Lipoproteins (low density) | Cell culture | GTP-binding protein | Reactive oxygen species | Cardiovascular disease | Post-translation | Heart diseases | Plaques | Statins | Cardiovascular system | NADPH-diaphorase | Cytokines | Coronary artery | Adenine | Inflammation | Low density lipoprotein | Cholesterol | Nitric-oxide synthase | Rho-associated kinase | Intermediates | Pleiotropy | Molecular modelling | Arteriosclerosis | Nitric oxide | Fibrosis | Hypertrophy
Journal Article